Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(14%)
Results Posted
100%(2 trials)
Terminated
1(14%)

Phase Distribution

Ph not_applicable
3
43%
Ph phase_4
1
14%
Ph phase_1
1
14%
Ph phase_2
1
14%
Ph phase_3
1
14%

Phase Distribution

1

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
3(42.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(2)
Terminated(2)
Other(1)

Detailed Status

Completed2
Terminated1
unknown1
Not yet recruiting1
Recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (14.3%)
Phase 21 (14.3%)
Phase 31 (14.3%)
Phase 41 (14.3%)
N/A3 (42.9%)

Trials by Status

terminated114%
completed229%
unknown114%
not_yet_recruiting114%
recruiting114%
withdrawn114%

Recent Activity

1 active trials
Showing 5 of 7
recruitingnot_applicable

Integrated Treatment for Enhancing Growth in Recovery During Adolescence

NCT06395467
not_yet_recruitingphase_1

A Phase I, Single-blind, Randomized Study of the Safety and Efficacy of Cellularized Integra® Using Autologous Burn-derived Stem Cells

NCT05344521
completedphase_2

Comparative Effectiveness of Two Acellular Matrices (Dermacell vs. Integra) for Management of Deep Diabetic Foot Ulcers

NCT03476876
unknownnot_applicable

Comparing the Clinical Outcomes of DermACELL® With Integra® Bilayer Wound Matrix

NCT03285698
terminatednot_applicable

Comparison of Skin Substitutes Used in Burn Care

NCT00676013
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT06395467Not Applicable

Integrated Treatment for Enhancing Growth in Recovery During Adolescence

Recruiting
NCT05344521Phase 1

A Phase I, Single-blind, Randomized Study of the Safety and Efficacy of Cellularized Integra® Using Autologous Burn-derived Stem Cells

Not Yet Recruiting
NCT03476876Phase 2

Comparative Effectiveness of Two Acellular Matrices (Dermacell vs. Integra) for Management of Deep Diabetic Foot Ulcers

Completed
NCT03285698Not Applicable

Comparing the Clinical Outcomes of DermACELL® With Integra® Bilayer Wound Matrix

Unknown
NCT00676013Not Applicable

Comparison of Skin Substitutes Used in Burn Care

Terminated
NCT02363543Phase 4

Comparison of Hyalomatrix and Integra Wound Matrix on Burn Wounds

Withdrawn
NCT00906672Phase 3

Medico Economic Evaluation of Dermal Substitute Integra® for Coverage of Inferior Limb Traumatic Skin Loss

Completed

All 7 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
7